Skip to content
PIL Logo

ACWY Vax Vaccine

Last Updated on eMC 13-Mar-2014 View document  | GlaxoSmithKline UK Contact details

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC.  For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 13-Mar-2014 and displayed until Current

Reasons for adding or updating:

  • Change to section 4 - how to report a side effect
  • Change to section 6 - date of revision

Updated on 21-Oct-2013 and displayed until 13-Mar-2014

Reasons for adding or updating:

  • Change to section 6 - date of revision

Updated on 29-Aug-2012 and displayed until 21-Oct-2013

Reasons for adding or updating:

  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to information about pregnancy or lactation

Updated on 25-Jan-2012 and displayed until 29-Aug-2012

Reasons for adding or updating:

  • Change to date of revision
  • Change to warnings or special precautions for use

Updated on 24-Mar-2011 and displayed until 25-Jan-2012

Reasons for adding or updating:

  • Improved Electronic Presentation

Updated on 10-Feb-2011 and displayed until 24-Mar-2011

Reasons for adding or updating:

  • Improved Electronic Presentation

Updated on 08-Jun-2010 and displayed until 10-Feb-2011

Reasons for adding or updating:

  • Improved Electronic Presentation

Updated on 03-Jun-2010 and displayed until 08-Jun-2010

Reasons for adding or updating:

  • Change to date of revision
  • Change due to user-testing of patient information

Updated on 28-Apr-2009 and displayed until 03-Jun-2010

Reasons for adding or updating:

  • Change/addition of instructions for reconstitution and/ or administration

Updated on 13-Aug-2008 and displayed until 13-Aug-2008

Reasons for adding or updating:

  • Improved Electronic Presentation
  • Change to date of revision
  • Change due to user-testing of patient information
  • Improved Electronic Presentation
  • Change due to user-testing of patient information
  • Change to date of revision
  • Change to storage instructions
  • Change to side-effects

Updated on 07-Jan-2004 and displayed until 13-Aug-2008

Reasons for adding or updating:

  • Update to PIL

Updated on 09-May-2002 and displayed until 07-Jan-2004

Reasons for adding or updating:

  • Update to PIL

Updated on 09-Apr-2001 and displayed until 09-May-2002

Reasons for adding or updating:

  • No reasons supplied

Company contact details

GlaxoSmithKline UK

Company image
Address

Stockley Park West, Uxbridge, Middlesex, UB11 1BT

Fax

+44 (0)208 990 4328

Medical Information e-mail
Telephone

0800 221 441

E-mail
Customer Care direct line

0800 221 441

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Active ingredients

acwy meningococcal polysaccharide

Legal categories

POM - Prescription Only Medicine

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue